rs371310428
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_018255.4(ELP2):c.1385G>A(p.Arg462Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000743 in 1,614,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R462L) has been classified as Pathogenic.
Frequency
Consequence
NM_018255.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELP2 | NM_018255.4 | c.1385G>A | p.Arg462Gln | missense_variant | 13/22 | ENST00000358232.11 | NP_060725.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELP2 | ENST00000358232.11 | c.1385G>A | p.Arg462Gln | missense_variant | 13/22 | 1 | NM_018255.4 | ENSP00000350967.6 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152076Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251084Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135680
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461820Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727214
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74408
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 11, 2023 | Published functional studies demonstrate a damaging effect on tRNA-induced acetyl-CoA hydrolysis activity (Kojic et al., 2021); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as c.1385 G>A p.(R462Q) due to use of alternate nomenclature; This variant is associated with the following publications: (PMID: 34653680, 28726809, 31028937, 32573669, 33393008, 34426522, 33510603, 33961281, 33742171, 36787709, 36360260, 33976153) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 17, 2022 | This variant is present in population databases (rs371310428, gnomAD 0.01%). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects ELP2 function (PMID: 33976153). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). ClinVar contains an entry for this variant (Variation ID: 870396). This variant is also known as p.R462Q. This missense change has been observed in individual(s) with ELP2-related intellectual disability syndrome (PMID: 32573669, 33393008, 33510603, 33976153, 34653680). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 527 of the ELP2 protein (p.Arg527Gln). - |
Intellectual disability, autosomal recessive 58 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Sep 02, 2022 | A heterozygous missense variant was identified, NM_001242875.2(ELP2):c.1580G>A in exon 14 of 23 of the ELP2 gene. This substitution is predicted to create a minor amino acid change from an arginine to a glutamine at position 527 of the protein; NP_001229804.1(ELP2):p.(Arg527Gln). The arginine at this position has high conservation (100 vertebrates, UCSC), and is located within a WD40 repeat (NCBI). In silico software predicts this variant to be damaging (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD population database at a global frequency of 0.0016% (4 heterozygotes, 0 homozygotes). This variant has been previously reported as pathogenic in two patients with syndromic global developmental delay (LOVD, Strauss, K. A. et al. (2018)). Different variants in the same codon resulting in a change to a tryptophan and leucine, have also been shown to cause intellectual disability (LOVD, ClinVar, Farwell, K. D. et al. (2015), Najmabadi, H. et al. (2011), Cohen, J. S. et al. (2015)). Based on information available at the time of curation, this variant has been classified as LIKELY PATHOGENIC. - |
Intellectual disability, profound Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Wainwright Lab, University Of Queensland | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at